Annji Pharmaceutical Co (ROCO:7754) Days Payable: 0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7754 Annji Pharmaceutical Co Ltd ROCO:7754
9 GF Score
Price NT$59.90
! 6 Warning Signs
View Full Analysis

What is Annji Pharmaceutical Co Days Payable?

Annji Pharmaceutical Co ROCO:7754 +0.50% 9 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates ROCO:7754 with a GF Score™ of 9/100. The stock has 6 warning signs investors should review. Among 701 Biotechnology companies, Annji Pharmaceutical Co ranks worse than 61.34% on this metric.

Annji Pharmaceutical Co's average Accounts Payable for the six months ended in Dec. 2025 was NT$0.00 Mil. Annji Pharmaceutical Co's Cost of Goods Sold for the six months ended in Dec. 2025 was NT$0.14 Mil. Hence, Annji Pharmaceutical Co's Days Payable for the six months ended in Dec. 2025 was 0.00.

The historical rank and industry rank for Annji Pharmaceutical Co's Days Payable or its related term are showing as below:

ROCO:7754' s Days Payable Range Over the Past 10 Years
Min: 0.48   Med: 3.58   Max: 64.94
Current: 64.94

During the past 5 years, Annji Pharmaceutical Co's highest Days Payable was 64.94. The lowest was 0.48. And the median was 3.58.

ROCO:7754's Days Payable is ranked worse than
61.34% of 701 companies
in the Biotechnology industry
Industry Median: 112.84 vs ROCO:7754: 64.94

Annji Pharmaceutical Co's Days Payable declined from Dec. 2024 (11.86) to Dec. 2025 (0.00). It may suggest that Annji Pharmaceutical Co accelerated paying its suppliers.

Annji Pharmaceutical Co Days Payable Historical Data

* Premium members only.

The historical data trend for Annji Pharmaceutical Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annji Pharmaceutical Co Days Payable Chart

Annji Pharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
0.00 0.00 0.00 0.48 6.67

Annji Pharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial 0.00 5.51 11.86 3.41 0.00

ROCO:7754 vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Annji Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annji Pharmaceutical Co Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annji Pharmaceutical Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Annji Pharmaceutical Co's Days Payable falls into.


ROCO:7754
9GF Score
Annji Pharmaceutical Co Ltd ROCO:7754
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annji Pharmaceutical Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Annji Pharmaceutical Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.115 + 0) / 1 ) / 6.295*365
=0.115 / 6.295*365
=6.67

Annji Pharmaceutical Co's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0.143*365 / 2
=0 / 0.143*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Annji Pharmaceutical Co (ROCO:7754) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Annji Pharmaceutical Co and its competitors. Over the past decade, Annji Pharmaceutical Co's Days Payable has ranged from 0.48 to 64.94. According to the industry distribution chart, Annji Pharmaceutical Co ranks #430 out of 701 companies in the Biotechnology industry, placing it in the top 61.3%.
Is Annji Pharmaceutical Co's Days Payable too high?
Annji Pharmaceutical Co's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 64.94. Based on the distribution chart, Annji Pharmaceutical Co ranks #430 out of 701 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Annji Pharmaceutical Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Annji Pharmaceutical Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Annji Pharmaceutical Co ranks #430 out of 701 companies for Days Payable. This places Annji Pharmaceutical Co in the lower half of its industry. The industry median Days Payable is 112.84. Historically, Annji Pharmaceutical Co's own Days Payable has ranged from 0.48 to 64.94 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Annji Pharmaceutical Co and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Annji Pharmaceutical Co's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annji Pharmaceutical Co stock overvalued right now?
Annji Pharmaceutical Co (ROCO:7754) has a current Days Payable of 0.00. The current Days Payable is 0.00. Annji Pharmaceutical Co's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Annji Pharmaceutical Co (ROCO:7754), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annji Pharmaceutical Co Business Description

Address Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.
9GF Score

Get the complete analysis for ROCO:7754

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$59.90
Price